Clinical trials may become more efficient as emerging tech transforms processes like study management, patient recruitment, and more. We look at how the clinical trial landscape is changing.
Across the world, clinical trial players are scrambling to adapt to the effects of the Covid-19 pandemic.
Researchers are already turning to measures like remote visits and delivering study materials to patients’ homes to keep trials running.
Meanwhile, a host of studies looking for Covid-19 therapies are moving at an unprecedented speed. In March, for example, the World Health Organization (WHO) launched its massive Solidarity clinical trial using “simplified procedures” that it hopes will shorten the timeline of its randomized trials by 80%.